A Comprehensive Strategy on the Modern Management of Type 1 and Type 2 Diabetes

Transcription

1 11 TH YEAR IN A UNIQUE NATIONAL SERIES A Comprehensive Strategy on the Modern Management of Type 1 and Type 2 Diabetes MEDICAL EDUCATION FOR HEALTHCARE PROFESSIONALS Making the Connection Between Patients & Providers Saturday, February 20, 2016 William A. Egan Civic & Convention Center Anchorage, Alaska Inspiring Medical Education

2 In its 11th year, the TCOYD Making the Connection continuing medical education program offers a unique opportunity to bridge patient and professional education, demonstrating the link between clinical lessons taught in the classroom and the real-life patient experience. The ultimate goal of this activity is to educate caregivers and clinicians about the most effective cutting-edge strategies to help patients with diabetes reach their treatment goals and avoid the associated acute and chronic complications. This activity will focus on four distinct areas of diabetes management and will integrate case presentations, as well as an audience response system into the lectures to facilitate more active participation. TARGET AUDIENCE The four areas of focus are: Behavioral and emotional aspects of diabetes care Oral agents for the treatment of type 2 diabetes and obesity Injectable therapies for use in patients with type 2 diabetes Cutting-edge management strategies for patients with type 1 diabetes In addition, this course is being held in tandem with a separate, yet similar, large-scale patient education conference that will give providers the opportunity to observe and interact with people who have diabetes and who are engaged in their own intensive educational environment. Making that connection with patients, providers will acquire new skills and insight into what empowers patients with diabetes to develop healthy self management of their condition. Course Director Steven V. Edelman, MD Clinical Professor of Medicine, UCSD School of Medicine Director, Diabetes Care Clinic, San Diego VA Medical Center Founder and Director, Taking Control Of Your Diabetes Faculty Steven V. Edelman, MD William Polonsky, PhD, CDE President, Behavioral Diabetes Institute Associate Clinical Professor, UCSD Ian Blumer, MD, FRCPC Charles H. Best Diabetes Centre University of Toronto J. Ross Tanner, DO, FACP Internal Medicine and Clinical Lipidology Diabetes and Lipid Clinic of Alaska This course is designed for diabetes healthcare providers including: endocrinologists, primary care physicians, nurse practitioners, physician assistants, certified diabetes educators, pharmacists, and other healthcare providers wanting to expand their knowledge of diabetes management.

3 PROGRAM AGENDA 7:30am 8:00am 8:15am 9:00am Registration & Continental Breakfast Visit Health Fair Program Overview & Introduction The Personal Side of Diabetes: Psychological Secrets to Successful Diabetes Management WILLIAM POLONSKY, PhD, CDE Learn, Laugh and Live Better with Diabetes This presentation is not a part of the accredited activity 10:10am Break with Refreshments 10:20am Cutting Edge Management of Type 1 Diabetes in 2016: Modern Insulins, Pumps, Pens, and Continuous Glucose Monitoring 11:25am Break 11:35am A Practical Approach to the Clinical Application of Injectable Agents in the Treatment of Type 2 Diabetes: Basal and Prandial Insulins and GLP-1 Receptor Agonists IAN BLUMER, MD, FRCPC 12:50pm Lunch & Visit Health Fair 2:00pm 3:00pm 3:15pm 4:30pm Combined Patient-Provider Workshop: Bad Doctor, Good Patient; Good Doctor, Bad Patient! WILLIAM POLONSKY, Ph D, CDE Break Saturday, February 20, :30am to 5:00pm Oral Agents for the Treatment of Type 2 Diabetes and Obesity: Designing an Individualized and Effective Treatment Approach J. ROSS TANNER, DO, FACP Closing Session: Making the Connection WILLIAM POLONSKY, Ph D, CDE

4 LEARNING OBJECTIVES Upon completion of this course, participants should be able to: 1 Discuss the different pathophysiologic defects associated with type 2 diabetes and how pharmacologic agents address these specific abnormalities. 2 Describe the new FDA-approved therapies for the treatment of obesity, including the safety and efficacy and how they can be combined with diabetes medications for obese patients with diabetes. 3 Discuss the issues of combination therapy with the currently available oral agents including metformin, TZDs, SFUs, SGLT-2 inhibitors, DPP4 inhibitors as well as GLP-1 receptor agonists. 4 Design rational and individualized treatment plans using mono- or combination therapy, including the optimal time for introducing each therapy. 5 Describe the advantages and limitations of modern insulin preparations and the various clinical strategies including combination therapy, split mixed, premixed, basal-bolus, and pump regimens. 6 Discuss patient-directed insulin titration strategies used in clinical practice for combination therapy and the basal bolus approach. 7 Review and describe the pathophysiology of type 2 diabetes as it relates to the role of incretin-based therapies. 8 Outline the most up to date clinical information on GLP-1 receptor agonists, including prescribing guidelines and safety issues. 9 Illustrate the physiologic secretion of insulin, glucagon, and amylin in the normal and diabetic state and propose a physiologic multiple daily injection regimen. 10 Identify appropriate candidates for pump therapy. 11 Design an easy-to-implement treatment plan for initiation of pump therapy and subsequent adjustments based on home and/or continuous glucose monitoring numbers. 12 Discuss scenarios illustrating the information that continuous glucose monitoring technology provides and effective therapeutic adjustments based on continuous glucose monitoring data. 13 Evaluate the physical and emotional barriers that prevent patients with diabetes from being persistent and adherent to their therapeutic regimen(s) thus preventing achievement of metabolic control. 14 Employ innovative and dynamic strategies for communication with patients to strengthen provider-patient relations and improve patient outcomes. Instructions To Receive Credit: To receive credit, please read the introductory CME/CE/CPE material, attend the entire meeting, and complete the online evaluation and attestation at the end of the conference. Pharmacists must complete the evaluation and attestation within 60 days of participation and complete the post-test, answering at least 70% of the questions correctly. Conference Syllabus & Slide Decks Conference registrants will be responsible for downloading presenter slide decks. Slide decks will be available online one week before the conference date. It is the responsibility of the participant to download the slide decks and bring them to the conference in a printed or electronic format if they deem necessary. Printed versions of the slide decks will not be distributed on the day of the conference. A small handout with pertinent information regarding the day s schedule and room locations, as well as evaluation and credit claiming instructions, will be provided on the day of the conference only.

5 Accreditation/Designation Statements This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Med-IQ and Taking Control Of Your Diabetes. Med-IQ is accredited by the ACCME to provide continuing medical education for physicians. AMA: Med-IQ designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 6.25 hours of Category I credit for completing this program. CBRN: Med-IQ is accredited by the California Board of Registered Nursing to provide continuing education to nurses. A current list of commercial supporters is available at tcoydcme.org Provider approved by the California Board of Registered Nursing, Provider Number CEP 14745, for 6.25 contact hours. Certified Diabetes Educators: To satisfy the requirement for renewal of certification by continuing education for the National Certification Board for Diabetes Educators (NCBDE), continuing education activities must be diabetes related and approved by a provider on the NCBDE list of Approved Providers ( NCBDE does not approve continuing education. Med-IQ is accredited by the ACCME, which is on the NCBDE list of Approved Providers. Pharmacists: Med-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education contact hours (0.625 CEUs) of credit for pharmacists. ACPE# L01-P. This knowledge-based activity is designed for all pharmacists. Others: Nurse practitioners and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available. Registration Online only: Registration fee: $20 Includes: Breakfast, lunch, snack, syllabus and downloadable slide decks. Register by: Wednesday, February 17, 2016 Cancellation: Call ext 17 No refunds after February 17, 2016 Registration is limited to 200 people. Register early, this program will sell out. Further information: Taking Control Of Your Diabetes 1110 Camino Del Mar, Suite B Del Mar, CA Phone: ext 17 Robyn@tcoyd.org Location: William A. Egan Civic & Convention Center 555 W 5th Avenue Anchorage, AK Parking: The closest parking garage is the 5th Avenue Garage. Cost is $1 per hour.